UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

Pharmacology & therapeutics (Oxford), 2019-05, Vol.197, p.83-102

2019

Volltextzugriff (PDF)

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Journal of psychopharmacology (Oxford), 2015-03, Vol.29 (3), p.289-299

2015

Volltextzugriff (PDF)

Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology

Journal of Psychopharmacology, 2016-12, Vol.30 (12), p.1259-1267

Hartogsohn, Ido

2016

Volltextzugriff (PDF)

Psychedelics as Medicines: An Emerging New Paradigm

Clinical pharmacology and therapeutics, 2017-02, Vol.101 (2), p.209-219

2017

Volltextzugriff (PDF)

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act

Neuropharmacology, 2018-11, Vol.142, p.143-166

2018

Volltextzugriff (PDF)

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

Neuropsychopharmacology (New York, N.Y.), 2017-10, Vol.42 (11), p.2105-2113

2017

Volltextzugriff (PDF)

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

Journal of clinical psychopharmacology, 2016-02, Vol.36 (1), p.77-81

2016

Volltextzugriff (PDF)

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

Psychopharmacology, 2018-02, Vol.235 (2), p.399-408

2018

Volltextzugriff (PDF)

Towards an understanding of psychedelic-induced neuroplasticity

Neuropsychopharmacology (New York, N.Y.), 2023-01, Vol.48 (1), p.104-112

2023

Volltextzugriff (PDF)

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Journal of psychopharmacology (Oxford), 2016-12, Vol.30 (12), p.1181-1197

2016

Volltextzugriff (PDF)

Classic hallucinogens in the treatment of addictions

Progress in neuro-psychopharmacology & biological psychiatry, 2016-01, Vol.64, p.250-258

2016

Volltextzugriff (PDF)

Psychedelics therapeutics: What we know, what we think, and what we need to research

Neuropharmacology, 2023-02, Vol.223, p.109257-109257, Article 109257

2023

Volltextzugriff (PDF)

Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials

Psychopharmacology, 2022-06, Vol.239 (6), p.1989-2010

2022

Volltextzugriff (PDF)

Psychiatry & the psychedelic drugs. Past, present & future

Neuropharmacology, 2018-11, Vol.142, p.200-218

2018

Volltextzugriff (PDF)

Psilocybin – Summary of knowledge and new perspectives

European neuropsychopharmacology, 2014-03, Vol.24 (3), p.342-356

2014

Volltextzugriff (PDF)

Modern Clinical Research on LSD

Neuropsychopharmacology (New York, N.Y.), 2017-10, Vol.42 (11), p.2114-2127

Liechti, Matthias E

2017

Volltextzugriff (PDF)

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Journal of psychopharmacology (Oxford), 2016-12, Vol.30 (12), p.1165-1180

2016

Volltextzugriff (PDF)

Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial

Journal of psychopharmacology (Oxford), 2023-07, Vol.37 (7), p.698-706

2023

Volltextzugriff (PDF)

Does the trip matter? Investigating the role of the subjective effects of psychedelics in persisting therapeutic effects

Neuropsychopharmacology (New York, N.Y.), 2023-01, Vol.48 (1), p.215-216

2023

Volltextzugriff (PDF)

Reviewing the Potential of Psychedelics for the Treatment of PTSD

The international journal of neuropsychopharmacology, 2020-06, Vol.23 (6), p.385-400

2020

Volltextzugriff (PDF)

Psychedelics: Where we are now, why we got here, what we must do

Neuropharmacology, 2018-11, Vol.142, p.7-19

2018

Volltextzugriff (PDF)

Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders

Journal of medicinal chemistry, 2024-01, Vol.67 (2), p.1024-1043

2024

Volltextzugriff (PDF)

Psychedelics: Threshold of a Therapeutic Revolution

Neuropharmacology, 2023-09, Vol.236, p.109610-109610, Article 109610

2023

Volltextzugriff (PDF)

Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer

Journal of psychopharmacology (Oxford), 2020-02, Vol.34 (2), p.155-166

2020

Volltextzugriff (PDF)

Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines

Neuropharmacology, 2022-11, Vol.219, p.109214, Article 109214

2022

Volltextzugriff (PDF)

1 – 25 von 263

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(257)
Mit Volltextzugriff
(200)

Publikationsform

Artikel
(263)

Sprache

Englisch
(263)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology

Psychedelics as Medicines: An Emerging New Paradigm

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

Towards an understanding of psychedelic-induced neuroplasticity

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Classic hallucinogens in the treatment of addictions

Psychedelics therapeutics: What we know, what we think, and what we need to research

Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials

Psychiatry & the psychedelic drugs. Past, present & future

Psilocybin – Summary of knowledge and new perspectives

Modern Clinical Research on LSD

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial

Does the trip matter? Investigating the role of the subjective effects of psychedelics in persisting therapeutic effects

Reviewing the Potential of Psychedelics for the Treatment of PTSD

Psychedelics: Where we are now, why we got here, what we must do

Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders

Psychedelics: Threshold of a Therapeutic Revolution

Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer

Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines

Aktive Filter

Suchergebnisse filtern